Top 10 Companies Shaping the Global Parathyroid Disorders Market (2026–2034) According to a newly published market research report by 24LifeSciences, global parathyroid disorders market is valued at USD 2.1 billion in 2026 and is projected to reach USD 3.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Parathyroid disorders are medical conditions resulting from the dysfunction of the parathyroid glands, four small glands located in the neck that regulate the body's calcium levels. These disorders lead to abnormal calcium levels in the blood, which can cause significant health issues such as brittle bones (osteoporosis), kidney stones, chronic fatigue, and muscle weakness. The primary disorders include hyperparathyroidism (overactive glands), hypoparathyroidism (underactive glands), and the rare parathyroid cancer. Market growth is primarily driven by an aging global population more susceptible to these conditions and the rising prevalence of chronic kidney disease (CKD), a major cause of secondary hyperparathyroidism. Furthermore, advancements in diagnostic techniques, such as more sensitive parathyroid hormone (PTH) assays, are facilitating earlier and more accurate detection. Key players like Amgen, with its calcimimetic drug Cinacalcet, and Abbott Laboratories, a leader in diagnostic solutions, are actively shaping the treatment landscape through innovation and strategic initiatives, contributing to market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9574/parathyroid-disorders-market

Global Rapid Diagnostics Market Expands as Point-of-Care Testing Becomes Central to Healthcare Global rapid diagnostics market is witnessing robust expansion as healthcare systems worldwide prioritize early detection, faster clinical decisions, and decentralized testing models. Valued at approximately USD 46.7 billion in 2024, the market is projected to grow from USD 50.1 billion in 2025 to around USD 76.4 billion by 2032, registering a CAGR of 6.2% during the forecast period. This growth reflects the increasing reliance on rapid diagnostic solutions across hospitals, clinics, and community settings to improve patient outcomes and optimize healthcare efficiency. Access the complete report https://www.24lifesciences.com/rapid-diagnostics-market-9182

Global Nanomedicine Market Enters a High-Growth Phase Driven by Precision Drug Delivery Global nanomedicine market is steadily advancing as healthcare systems increasingly adopt precision-based therapeutic and diagnostic solutions. Valued at USD 164 million in 2024, the market is projected to grow from USD 175 million in 2025 to USD 260 million by 2032, registering a CAGR of 6.9% over the forecast period. This growth trajectory highlights the expanding clinical acceptance of nanoscale technologies designed to enhance treatment efficacy, reduce toxicity, and improve patient outcomes across complex disease areas. Access the complete report https://www.24lifesciences.com/nanomedicine-market-9129

What Is the Future of the INAAT Market? Growth Forecasts & Molecular Diagnostics Insights Global Isothermal Nucleic Acid Amplification Technology (INAAT) market is undergoing rapid transformation as healthcare systems increasingly prioritize fast, accurate, and decentralized diagnostic solutions. Valued at USD 6.49 billion in 2024, the market is projected to reach USD 12.02 billion by 2031, expanding at a CAGR of 9.4% during the forecast period. This sustained growth reflects rising demand for point-of-care molecular diagnostics, expanding infectious disease surveillance, and continuous innovation in amplification technologies that operate without complex thermal cycling. Read the full analysis https://www.24lifesciences.com/isothermal-nucleic-acid-amplification-technology-inaat-market-8419

The global market for monkeypox testing has emerged as a critical component of infectious-disease diagnostics, especially in light of recent outbreaks and renewed global attention on zoonotic viruses. As the disease spreads into newer geographies and public-health authorities emphasize early detection and containment, demand for reliable, rapid, and accessible monkeypox diagnostic solutions is growing steadily. With rising awareness, improved surveillance networks, and investment in diagnostic infrastructure, the market is poised for a significant expansion over the next decade. https://www.factmr.com/report/monkeypox-testing-market